Top Companies in the Prepacked Chromatography Columns Market | Industry Leading Players Statistics Data by VMR
Chromatography is a technique for isolating a wide range of medication classes and components, including plant extracts, glycosides, amino acids, and others.
Market Overview:
The Global Prepacked Chromatography Columns Market is valued at USD 1,929.5Million in the year 2021 and is projected to reach a value of USD 2,344.4 Million by the year 2028. Chromatography is known as a separation technique, that is been widely used to isolate a large number of drug classes and components like glycosides, plant extracts, amino acids, and others. Moreover, it further plays a major role in the purification of biopharmaceutical products. Prepacked Chromatography Columns are filled with the stationary phase and they can be directly used by attaching to chromatography systems. Several pre-packed chromatography column manufacturers are increasing their global footprint to enhance manufacturing capacity, which is projected to drive market growth over the forecast period. For example, Repligen Corporation, a bioprocessing process equipment manufacturer, announced the installation of eight manufacturing suites in May 2019 to fulfill the growing demand for its large-scale OPUS prefilled chromatography columns, with sales up more than 40% year over year. Two manufacturing suites in Ravensburg, Germany, and six suites in Waltham, Massachusetts are being added to the company's OPUS capacity.
List of Top Players in the Prepacked Chromatography Columns Market:
Company Name |
Revenue in USD |
|
$6 Billion |
|
$592 Million |
|
$37 Million |
|
$3 Billion |
|
$18 Billion |
|
$3 Billion |
|
$98 Million |
|
$3 Billion |
|
$39 Billion |
|
$2 Billion |
Agilent Technologies Inc. was incorporated in Delaware in May 1999. Agilent is a leader in life sciences, diagnostics, and applied chemical markets. The company provides laboratories worldwide with instruments, services, consumables, applications, and expertise, enabling customers to gain the insights they seek. Agilent's expertise and trusted collaboration give them the highest confidence in their solutions. For the fiscal year ended October 31, 2021, the company has three business segments comprising the life sciences and applied markets business, the diagnostics and genomics business, and the Agilent CrossLab business. The company sells its products primarily through direct sales, but also utilizes distributors, resellers, manufacturers' representatives, and electronic commerce. As of October 31, 2021, the company employed approximately 17,000 people worldwide. The company’s primary research and development and manufacturing sites are in California, Colorado, Delaware, Massachusetts, Texas, Vermont, and Washington in the U.S. and in Australia, China, Denmark, Germany, Italy, Japan, Malaysia, Singapore, and the United Kingdom.
Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that increase efficiencies in the process of manufacturing biological drugs. The company is inspiring advances in bioprocessing for the customers the company serves; primarily biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide. The corporate headquarters of the company are located in Waltham, Massachusetts, with additional administrative and manufacturing operations worldwide. The majority of the manufacturing sites are located within the U.S. (California, Massachusetts, New Jersey, and New York), and outside of the U.S., the company has sites in Estonia, France, Germany, Ireland, the Netherlands, and Sweden.
Merck Millipore is a division of Merck KggA. Merck is a leading science and technology company, that operates across healthcare, life science, and electronics. Around 58,000 employees work to make a positive difference in millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene-editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2020, Merck generated sales of € 17.5 billion in 66 countries. Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Electronics.
Founded in 1952, Bio-Rad is based in Hercules, California. Bio-Rad Laboratories, Inc. is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. The company is listed on the New York Stock exchange with the symbol (NYSE: BIO and BIOb). With a focus on quality and customer service for 70 years, their products advance the discovery process and improve healthcare. Their customers include university and research institutions, hospitals, public health, and commercial laboratories, biotechnology and pharmaceutical companies, as well as applied laboratories that include food safety and environmental quality. The company has a global network of operations with approximately 7,900 employees worldwide. Bio-Rad had revenues of $2.9 billion in 2021.
GE Healthcare is the $17 billion* healthcare business of GE. The company is listed on the New York Stock exchange with a symbol (NYSE: GE). As a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, GE Healthcare enables clinicians to make faster, more informed decisions through intelligent devices, data analytics, applications, and services, supported by its Edison intelligence platform. With over 100 years of healthcare industry experience and around 47,000 employees globally, the company operates at the center of an ecosystem working toward precision health, digitizing healthcare, helping drive productivity, and improving outcomes for patients, providers, health systems, and researchers around the world.
Founded in 1946, Pall Corporation is based in Port Washington, New York. Pall Corporation is a filtration, separation, and purification leader providing solutions to meet the critical fluid management needs of customers across the broad spectrum of life sciences and industry. Pall works with customers to advance health, safety, and environmentally responsible technologies. The Company’s engineered products enable process and product innovation and minimize emissions and waste. Pall Corporation serves customers worldwide.
Phenomenex was incorporated in 1982 and is headquartered in Torrance, California. Phenomenex is a global technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers in industrial, clinical research, government, and academic laboratories. From drug discovery and pharmaceutical development to food safety and environmental analysis, Phenomenex chromatography solutions accelerate science and help researchers improve global health and well-being. Phenomenex Inc. is now proud to be a part of Danaher Corporation's Life Sciences group.
Shimadzu Corporation was founded in 1875 and is headquartered in Kyoto, Japan. Shimadzu Corporation operates in various fields such as testing and measuring instruments, medical systems, aircraft equipment, and industrial machinery and equipment. For the development of photoimmunotherapy, Shimadzu has also signed a separate Cooperative Research and Development Agreement with the National Cancer Institute and a joint development agreement with the National Cancer Center Hospital East to advance the development of measurement technologies for photoimmunotherapy.
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. The company’s mission is to enable the customers to make the world healthier, cleaner, and safer whether their customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics, or the developing and manufacturing of life-changing therapies. The company’s global team delivers an unrivaled combination of innovative technologies, purchasing convenience, and pharmaceutical services through their industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD.
Waters Corporation was incorporated in 1958 and is headquartered in Massachusetts, United States. The company is listed on the New York Stock exchange with a symbol (NYSE: WAT). Waters Corporation is the world's leading specialty measurement company and has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, and food sciences for more than 60 years. With more than 7,400 employees worldwide, Waters operates directly in 35 countries, including 14 manufacturing facilities, and with products available in more than 100 countries.
Read Latest Blog Top Companies in the Dunnage Packaging Market: https://v-mr.biz/dunnage-packaging-market
Get a Free Sample Here: https://www.vantagemarketresearch.com/prepacked-chromatography-columns-market-1470/request-sample
For More Information about each of these companies.
Vantage Market Research Report comes up with a detailed analysis of each major player in the industry. The Study provides Global market size & share, Emerging trends, an in-depth analysis of key players, Development opportunities, Sales, and a Revenue Forecast.